CN102406859A - External traditional Chinese medicine composition for treating hepatitis B - Google Patents
External traditional Chinese medicine composition for treating hepatitis B Download PDFInfo
- Publication number
- CN102406859A CN102406859A CN2011103945038A CN201110394503A CN102406859A CN 102406859 A CN102406859 A CN 102406859A CN 2011103945038 A CN2011103945038 A CN 2011103945038A CN 201110394503 A CN201110394503 A CN 201110394503A CN 102406859 A CN102406859 A CN 102406859A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine composition
- chinese medicine
- traditional chinese
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses an external traditional Chinese medicine composition for treating hepatitis B. The external traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 20-40 parts of white mustard seed, 7-13 parts of dragon's blood, 5-15 parts of croton, 20-35 parts of tabasheer, 15-35 parts of asafetida, 5-10 parts of wofberry bark, 0.5-1 part of musk and 140-160 parts of human milk. The traditional Chinese medicine composition embodies the characteristics of traditional Chinese medicine and western medicine treatment, and has the effects of unique, rapid, short and stable treatment effect, no recurrence and the like for chronic liver diseases. The external traditional Chinese medicine composition is a pure natural traditional Chinese medicine, is convenient for use, and is clinically verified to have rapid acting, definite treatment effect, high effective rate and good long-term effect. The traditional Chinese medicine composition has the advantages of low cost, good treatment effect and the like.
Description
Technical field
The present invention relates to a kind of external medicine composition of treating hepatitis B.
Background technology
Viral hepatitis is the general designation of multiple hepatopathy, and hepatitis medically can be divided into first, second, third, fourth, penta, oneself, seven types of heptan.Viral hepatitis causes swelling of liver cell, is to spread one of extensively very harmful infectious disease in the world.Wherein hepatitis B be popular the most extensively, the most serious a kind of infectious hepatitis of harm.Hepatitis B is the liver injury that is caused by hepatitis B virus, the primary disease extend over the entire globe.If the early symptom of hepatitis B and performance as loss of appetite, digestive function are poor, feed back abdominal distention, do not have hunger sensation, detest the greasy food feed that the consumes oil vomiting that just can cause nausea are easy tired after movable.The method and the medicine of treatment hepatopathy are a lot, and aim of the present invention is to provide a kind of cost low, the externally applied ointment that therapeutic effect is good.
Summary of the invention
To above-mentioned prior art, the invention provides a kind of external medicine composition of treating hepatitis B, its special effect, instant effect, short treating period, stable curative effect and difficult recurrence.
The present invention realizes through following technical scheme:
A kind of external medicine composition of treating hepatitis B is processed by following bulk drugs: 20～40 parts of Semen Sinapis Albaes, 7～13 parts of Sanguis Draxonis; 5～15 parts of Fructus Crotonis, 20～35 parts of Concretio Silicea Bambusaes, 15～35 parts of Resina Ferulaes; 5～10 parts of Cortex Lycii, 0.5～1 part in Moschus, 140～160 parts of human milks.
Preferably, process: 22 parts of Semen Sinapis Albaes, 12 parts of Sanguis Draxonis, 8 parts of Fructus Crotonis, 26 parts of Concretio Silicea Bambusaes, 30 parts of Resina Ferulaes, 10 parts of Cortex Lycii, 1 part in Moschus, 150 parts of human milks by following bulk drugs.
Preferably, process: 37 parts of Semen Sinapis Albaes, 10 parts of Sanguis Draxonis, 10 parts of Fructus Crotonis, 30 parts of Concretio Silicea Bambusaes, 28 parts of Resina Ferulaes, 8 parts of Cortex Lycii, 0.8 part in Moschus, 140 parts of human milks by following bulk drugs.
Preferably, process: 26 parts of Semen Sinapis Albaes, 11 parts of Sanguis Draxonis, 12 parts of Fructus Crotonis, 31 parts of Concretio Silicea Bambusaes, 32 parts of Resina Ferulaes, 5 parts of Cortex Lycii, 1 part in Moschus, 160 parts of human milks by following bulk drugs.
The method for preparing of the external medicine composition of said treatment hepatitis B is: get each crude drug except that human milk, the porphyrize powder is crossed 200 mesh sieves, mixes, and adds human milk, stirs into paste, promptly gets.
In the prescription of the present invention, the pharmacological action of each raw material and compatibility characteristics are summarized as follows:
Semen Sinapis Albae, Concretio Silicea Bambusae, Cortex Lycii: the bar expectorant of regulating the flow of vital energy, eliminating stagnation is conciliate, and removing heat from blood removes and steams.
Dragon's blood, asafoetide: promoting blood circulation and removing blood stasis, remove the broken knot of disease, passing corpse can go out.
Fructus Crotonis: the circulation of qi promoting intestinal stasis relieving ， Po mass in the abdomen hypochondriac lump.
Moschus: have one's ideas straightened out and ward off dirty detoxifcation dissipating blood stasis.
All medicines share, and work the bar phlegm of regulating the flow of vital energy, the diffusing stasis of blood of detoxifcation, remove the broken knot of disease, reach the effect of combatting poison with poison.
The present invention is a secret prescription handed down in the family from generation to generation, and according to China's traditional medical theory, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs cures mainly hepatitis B, and therapeutic modality is: external, plaster is affixed on liver, and be a course of treatment January, pastes 7 days (pasted continuously 7 days, all the other did not paste in 21 days) course of treatment.
Side effect:, do not find toxic and side effects through clinical observations in 25 years of statistic record are arranged.
Contraindication: anemia of pregnant woman, renal function injury and allergic constitution person forbidding.
Chinese medicine composition of the present invention has been given prominence to the characteristic of western medicines in treatment, and chronic hepatopathy has been played special effect, fast, short, stable and effect such as do not recur.Great three positive changes virus and carried three months, adhere to that be consolidation half a year, and noinvasive is painless.Natural Chinese medicines, easy to use, through clinical verification, instant effect, determined curative effect, effective percentage is high, and long-term effect is good.Chinese medicine composition of the present invention has advantages such as cost is low, good effect.
The specific embodiment
Below in conjunction with embodiment, clinical data and case the present invention is further described.
The external medicine composition of embodiment 1 preparation treatment hepatitis B
Prescription is: Semen Sinapis Albae 22 grams, and Sanguis Draxonis 12 grams, Fructus Crotonis 8 grams, Concretio Silicea Bambusae 26 grams, Resina Ferulae 30 restrains, Cortex Lycii 10 grams, Moschus 1 gram, human milk 150 grams (this is the consumption of potion, down together).
Method for preparing is: get each crude drug except that human milk, the porphyrize powder sieves, and mixes, and adds human milk, stirs into paste, promptly gets.
During treatment, external is coated on the drug of topical application with Chinese medicine composition and sticks (consumption that coated weight is potion), is affixed on liver then.
The external medicine composition of embodiment 2 preparation treatment hepatitis B
Prescription is: Semen Sinapis Albae 37 grams, Sanguis Draxonis 10 grams, Fructus Crotonis 10 grams, Concretio Silicea Bambusae 30 grams, Resina Ferulae 28 grams, Cortex Lycii 8 grams, Moschus 0.8 gram, human milk 140 grams.
Method for preparing is: get each crude drug except that human milk, the porphyrize powder sieves, and mixes, and adds human milk, stirs into paste, promptly gets.
The external medicine composition of embodiment 3 preparation treatment hepatitis B
Prescription is: Semen Sinapis Albae 26 grams, Sanguis Draxonis 11 grams, Fructus Crotonis 12 grams, Concretio Silicea Bambusae 31 grams, Resina Ferulae 32 grams, Cortex Lycii 5 grams, Moschus 1 gram, human milk 160 grams.
Method for preparing is: get each crude drug except that human milk, the porphyrize powder sieves, and mixes, and adds human milk, stirs into paste, promptly gets.
The external medicine composition of embodiment 4 preparation treatment hepatitis B
Prescription is: Semen Sinapis Albae 20 grams, Sanguis Draxonis 13 grams, Fructus Crotonis 5 grams, Concretio Silicea Bambusae 35 grams, Resina Ferulae 15 grams, Cortex Lycii 10 grams, Moschus 1 gram, human milk 150 grams.
Method for preparing is: get each crude drug except that human milk, the porphyrize powder sieves, and mixes, and adds human milk, stirs into paste, promptly gets.
The external medicine composition of embodiment 5 preparation treatment hepatitis B
Prescription is: Semen Sinapis Albae 40 grams, Sanguis Draxonis 7 grams, Fructus Crotonis 15 grams, Concretio Silicea Bambusae 20 grams, Resina Ferulae 35 grams, Cortex Lycii 5 grams, Moschus 0.5 gram, human milk 160 grams.
Method for preparing is: get each crude drug except that human milk, the porphyrize powder sieves, and mixes, and adds human milk, stirs into paste, promptly gets.
Clinical data:
Patient's data: from April, 1986, have outpatient 4689 people of complete data, at 11～57 years old age, the course of disease is the longest 18 years; All suffer from hepatitis B (overwhelming majority is the hepatitis B great three positive of chronic hepatitis of active stage), wherein, male 3908 people; 45 years old mean age, women 781 people, 40 years old mean age.
Diagnosis basis: ten of liver functions, six of hepatitis B, ultrasound diagnosis, oral account general lassitude, weak, loss of appetite is felt sick and is detested oil, yellow complexion, yellow urine.
Therapeutic Method: 4689 routine patients are divided into treatment group and matched group at random, and wherein, 3201 examples are organized in treatment, matched group 1488 examples, and treatment group patient uses the medicine external application of embodiment 3 preparations, and once a day, every month pastes seven days is a course of treatment, treats three courses of treatment.The YIGANLING of the oral routine dose of matched group, and the interferon of injection routine dose.
The therapeutic evaluation standard:
Cure: liver histological inspection Non Apparent Abnormality, great three positive transfers virus to and carries.
Invalid: the state of an illness does not have significant change.
Therapeutic outcome: 3201 examples are organized in treatment, cure 2732 examples, invalid 469 examples, cure rate 85.3%.Contrast 1488 examples, cure 737 examples, invalid 751 examples, cure rate 49.5%.It is thus clear that traditional Chinese medicine composition for treating effect of the present invention obviously is superior to YIGANLING.
Case:
Case 1 tunnel certain, man 39 years old, hepatitis 10 years is surplus, ten index inspections of liver function, great three positive, transaminase are high; Uncomfortable liver area, weak, insomnia, loss of appetite; Take the medicine of multiple treatment hepatopathy, once repeatedly hospitalization was not all seen and was clearly better, and used plaster of the present invention (embodiment 3 preparations) treatment to continue to check after 3 courses of treatment; Changeed virus and carried,, paid a return visit after 7 years and do not have recurrence for after treatment continues to have treated three courses of treatment again.
Case 2 cloth, woman 25 years old, hepatitis B, liver function index inspection great three positive, transfusion once, injection of interferon, the SM commentaries on classics of not getting better 3 years more.Use ointment of the present invention (embodiment 3 preparation) after three courses of treatment, through liver function test, changeed virus and carried, liver histological inspection Non Apparent Abnormality.For consolidating curative effect, continue again to treat 3 courses of treatment, pay a return visit after 2 years and do not have recurrence.
Case 3 fields, man 17 years old, hepatitis B great three positive, the weak anorexia of yellowish complexion; The commentaries on classics of not getting better 2 years of Chinese medicine and western medicine, interferon, SM more, use plaster of the present invention (embodiment 3 preparations) after; Check 3 courses of treatment has been changeed virus and has been carried, and continued treatment is done to consolidate three courses of treatment again, does not see recurrence after 3 years.
Case 4 journeys, 45 years old hepatitis B great three positive of man, liver's dull pain, inappetence, weak hospitalization is once taken the medicine of multiple Chinese medicine and western medicine treating the liver nourishing the liver and is not felt any better, and uses three courses of treatment of plaster of the present invention (embodiment 1 preparation), and checking has changeed virus and has carried.Do not continue treatment, follow up a case by regular visits to after 6 years and do not have recurrence.
5 Weis of case, man 35 years old, hepatitis B great three positive; Be not interrupted the medicine of taking the treatment hepatitis B in 15 years; Do not see to be clearly better that check has been changeed virus and carried after using plaster of the present invention (embodiment 1 preparation) treatment, continuing three courses of treatment; Continue to have used three courses of treatment to consolidate curative effect again, follow up a case by regular visits to after 3 years and do not see recurrence.
Case 6 single certain, man 11 years old, the hepatitis B great three positive, the Chinese and western drugs that continues to take the treatment hepatitis B was not controlled the small three positive state of an illness in 9 months, made progress to be great three positive.Since having used plaster of the present invention (embodiment 2 preparations), just transfer virus to after three courses of treatment and carry, adhere to having used and do half a year to consolidate, follow up a case by regular visits to after 3 years and do not have recurrence.
Case 7 Cui, man 26 years old, the hepatitis B great three positive, the transaminase is high, the clinical manifestation heating, inappetence, complexion eyeball xanthochromia, symptom such as lower limb are aching and limp was once used the liver protecting and ALT lowering jaundice eliminating medicine, did not have effect.3 courses of treatment after using plaster of the present invention (embodiment 2 preparations), changeed virus and carried, three courses of treatment of SM, do not follow up a case by regular visits to recurrence after 2 years.
Claims (5)
1. an external medicine composition of treating hepatitis B is characterized in that, is processed by following bulk drugs: 20～40 parts of Semen Sinapis Albaes; 7～13 parts of Sanguis Draxonis, 5～15 parts of Fructus Crotonis, 20～35 parts of Concretio Silicea Bambusaes; 15～35 parts of Resina Ferulaes; 5～10 parts of Cortex Lycii, 0.5～1 part in Moschus, 140～160 parts of human milks.
2. a kind of external medicine composition of treating hepatitis B according to claim 1 is characterized in that, is processed by following bulk drugs: 22 parts of Semen Sinapis Albaes, 12 parts of Sanguis Draxonis; 8 parts of Fructus Crotonis, 26 parts of Concretio Silicea Bambusaes, 30 parts of Resina Ferulaes; 10 parts of Cortex Lycii, 1 part in Moschus, 150 parts of human milks.
3. a kind of external medicine composition of treating hepatitis B according to claim 1 is characterized in that, is processed by following bulk drugs: 37 parts of Semen Sinapis Albaes, 10 parts of Sanguis Draxonis; 10 parts of Fructus Crotonis, 30 parts of Concretio Silicea Bambusaes, 28 parts of Resina Ferulaes; 8 parts of Cortex Lycii, 0.8 part in Moschus, 140 parts of human milks.
4. a kind of external medicine composition of treating hepatitis B according to claim 1 is characterized in that, is processed by following bulk drugs: 26 parts of Semen Sinapis Albaes, 11 parts of Sanguis Draxonis; 12 parts of Fructus Crotonis, 31 parts of Concretio Silicea Bambusaes, 32 parts of Resina Ferulaes; 5 parts of Cortex Lycii, 1 part in Moschus, 160 parts of human milks.
5. each described a kind of method for preparing of treating the external medicine composition of hepatitis B in the claim 1～4, it is characterized in that: get each crude drug except that human milk, the porphyrize powder is crossed 200 mesh sieves, mixes, and adds human milk, stirs into paste, promptly gets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110394503.8A CN102406859B (en) | 2011-12-01 | 2011-12-01 | External traditional Chinese medicine composition for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110394503.8A CN102406859B (en) | 2011-12-01 | 2011-12-01 | External traditional Chinese medicine composition for treating hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102406859A true CN102406859A (en) | 2012-04-11 |
| CN102406859B CN102406859B (en) | 2014-07-23 |
Family
ID=45909394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110394503.8A Expired - Fee Related CN102406859B (en) | 2011-12-01 | 2011-12-01 | External traditional Chinese medicine composition for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102406859B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1197667A (en) * | 1998-03-11 | 1998-11-04 | 张学勤 | Externally used medicine for hepatitis B |
| CN1223127A (en) * | 1998-01-15 | 1999-07-21 | 韩钰 | Tongguanshugan ointment and preparation process thereof |
-
2011
- 2011-12-01 CN CN201110394503.8A patent/CN102406859B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1223127A (en) * | 1998-01-15 | 1999-07-21 | 韩钰 | Tongguanshugan ointment and preparation process thereof |
| CN1197667A (en) * | 1998-03-11 | 1998-11-04 | 张学勤 | Externally used medicine for hepatitis B |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102406859B (en) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102441081A (en) | Medicament for treating gout and its preparation method | |
| CN102641434A (en) | Capsule capable of promoting blood circulation, removing meridian obstruction and removing paralysis and preparing technology thereof | |
| CN100536901C (en) | Chinese medicine for treating burn, scald and frostbite | |
| CN102058784A (en) | Medicinal composition for treating pulmonary heart disease and application thereof | |
| CN102008610A (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN101897882B (en) | Medicament for treating and breast lobular hyperplasia and cyst | |
| CN101745047A (en) | Chinese medicinal composition for treating gout disease and preparation method thereof | |
| CN106963921A (en) | It is a kind of to treat external medicine composition of the proliferation of mammary gland and preparation method thereof | |
| CN102579999A (en) | Medicine for treating carcinous fever and preparation method thereof | |
| CN102302559B (en) | Medicament for treating respiratory system diseases and application thereof | |
| CN114652674A (en) | Blood circulation promoting and pain relieving ointment and preparation method thereof | |
| CN102716381B (en) | Traditional Chinese medicine used for treating appendicitis | |
| CN102406859B (en) | External traditional Chinese medicine composition for treating hepatitis B | |
| CN102824576A (en) | Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof | |
| CN101658635B (en) | Chinese medical preparation for treating burn and scald and preparation method | |
| CN105412206A (en) | Traditional Chinese medicine preparation with relaxing tendon and dissipating hard mass effects | |
| CN102228559B (en) | Externally applied ointment for treating children eczema | |
| CN100566741C (en) | A kind of antipsoriatics thing | |
| CN103961490A (en) | Compound medicine for treating wind-cold-dampness arthralgia and preparation method thereof | |
| CN104096170B (en) | External-use ultra-fine powder traditional Chinese medicine for weight loss and preparation method thereof | |
| CN102872342A (en) | Chinese medicinal composition for treating gastric ulcer | |
| CN102114199B (en) | Traditional Chinese medicine for treating bone cancer | |
| CN102258589B (en) | Deer blood medicinal wine for treating rheumatoid arthritis | |
| CN101972306B (en) | Chinese medicinal capsule for treating chronic pelvic inflammatory disease | |
| CN106421534A (en) | Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 Termination date: 20151201 |
|
| EXPY | Termination of patent right or utility model |